Global Asthma & COPD Market Report: 2015 Edition - New Report by Koncept Analytics

1
Global Asthma Market Report --------------------
--------------------- 2015
View Report Details
2
View Report Details

• Executive Summary
• Asthma is a common chronic disease linking the
  airway in the lungs that affects the people of
  all age groups. The airways or bronchial tubes,
  allow air to come in and out of the lungs. The
  airway of asthmatic patients is generally
  inflamed and becomes swollen over time. This
  makes it difficult for air to move in and out of
  the lungs, causing symptoms such as coughing,
  wheezing, shortness of breath and/ or chest
  tightness.
• The prevalence of asthma is expected to increase
  significantly in the coming years. The market for
  asthma drugs is driven by various factors
  including increasing global spending on
  medicines, increasing tobacco and cigarette
  consumption, rising prevalence of
  non-communicable diseases, more use of biologics,
  and increasing healthcare expenditure worldwide.
  The major upcoming trends in the asthma market
  include introduction of new severe asthma and
  Chronic Obstructive Pulmonary Disease (COPD)
  drugs, and introduction of new mechanisms that
  will help drive the market. However, there are
  certain challenges hindering the growth of the
  market. Such challenges include increased pricing
  pressures, patent expiries and introduction of
  generic drugs in the market.
• The market for asthma and COPD drugs represents
  an area of potential opportunity in both
  developed and developing countries. Due to
  effectiveness and advancements in technology, a
  large number of companies are focusing to develop
  innovative asthma and COPD drugs and treatments.
  Further, the companies are combining businesses
  and spending comprehensively on research and
  development to develop effective treatment
  methods for asthma.
• The present report provides a comprehensive
  analysis of the global asthma COPD market with
  focus on regions like the U.S. and European
  Union. Furthermore, market dynamics such as the
  industry trends and development, the underlying
  growth drivers and major issues faced by the
  industry are elicited. On the contention front,
  the market is personified by the intense
  competition in terms of research and development
  of novel therapeutic molecules. The leading
  players operating in the industry include
  AstraZeneca, Merck and Co., Roche, Sanofi and
  Novartis which are also profiled in this report.

3
The Global Respiratory Market has high growth
potential due to expected increase in the
treatment rate in the coming years
Global Respiratory Market (2012-2018E)

• For the year 2014, the global respiratory market
  is estimated to have reached US.. billion and is
  further estimated to increase to US.. billion by
  2018, increasing from US... billion in 2012,
  registering a CAGR of .. for the period
  2012-2018.
• The U.S. is estimated to have held the maximum
  share in the global respiratory market with ..,
  followed by the top EU5 region with .. share.
  Japan with .. share in the respiratory market
  was followed by Latin America with .. share.
• The global respiratory drugs market reached US..
  billion in 2014 compared to US.. billion in
  2013, a decline of ... The market for
  respiratory drugs is further estimated to fall by
  .. in 2015 with revenues reaching US... billion

Global Respiratory Market by Regions (2014E)
Global Respiratory Therapeutics Market
(2010-2015E)
4
Both prevalence and mortality for respiratory
diseases is increasing, which is likely to bring
significant opportunity for the industry
Global Asthma Market by Value (2012-2022E)

• The global asthma market stood at US.. billion
  in 2012, and is estimated to have reached US...
  billion by the end of 2014. The global asthma
  market is further estimated to reach US..
  billion by 2022. The market is expected to grow
  modestly at a CAGR of .. for the period spanning
  2012-2017.
• In 2014, the global COPD market is estimated to
  have reached US.. billion increasing from US..
  billion in 2012. The market is further estimated
  to reach US... billion and US.. billion by the
  end of 2017 and 2022 respectively.
• By 2017, the U.S. is expected to hold the maximum
  share in the global asthma/COPD market with ..
  share, followed by the five major countries of
  the European Union which are expected to hold
  share. The BRIC nations will be holding .. share
  in the global asthma/COPD market followed by
  Japan with .

Global COPD Market by Value (2012-2022E)
Global Asthma/COPD Market by Region (2017E)
5
A set of new treatment opportunities are now on
the verge of reaching the market, for sever
asthma treatment, thus driving the overall asthma
market..
Global Asthma/COPD Therapeutics Market
(2010-2015E)

• In 2014, the global asthma/COPD therapeutics
  market reached US... billion registering an
  annual decline of .. from the previous years
  revenue of US.. billion. The market is estimated
  to decline further by .. and reach US...billion
  by the end of 2015.
• The global severe asthma market is estimated to
  have reached US.. Million in 2014 increasing
  from US.. million in the previous fiscal. The
  market for severe asthma is expected to rise
  significantly over the years and reach
  US...billion by the end of 2022.
• The severe asthma biologics market is estimated
  to have three different inhibitors category by
  the end of year 2022. Of the three inhibitors,
  IL-5 Inhibitors is estimated to capture .. of
  the total market followed by IL-13
  Inhibitors/IL-4 Inhibitors with share.

Global Severe Asthma Biologics Market Forecast
(2013-2022E)
Global Severe Asthma Biologics Market by Drugs
(2022E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Asthma Market . To know more about this report
or for any customized research requirement,
please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com